Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease

J Am Geriatr Soc. 2008 Apr;56(4):765-7. doi: 10.1111/j.1532-5415.2008.01612.x.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Botulinum Toxins, Type A / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Neuromuscular Agents / administration & dosage*
  • Parkinson Disease / complications*
  • Parotid Gland
  • Sialorrhea / complications
  • Sialorrhea / drug therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A